Literature DB >> 28790728

NEUROLEPTIC MALIGNANT SYNDROME.

S K Mayanil1, U R Tampi2.   

Abstract

Keywords:  Creatine phosphokinase (CPK); Neuroleptic malignant syndrome; Organic psychotic condition

Year:  2017        PMID： 28790728      PMCID： PMC5532091          DOI： 10.1016/S0377-1237(17)30187-9

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  5 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

2.  [Neuroleptic malignant syndrome in the elderly: description of 4 patients].

Authors:  J M Cruz; M Pato; X A Gómez; A Batalla; C Cutrin
Journal:  An Med Interna       Date:  1997-08

3.  Carbamazepine in the treatment of neuroleptic malignant syndrome.

Authors:  P Thomas; M Maron; C Rascle; O Cottencin; G Vaiva; M Goudemand
Journal:  Biol Psychiatry       Date:  1998-02-15       Impact factor: 13.382

4.  Case-control study of neuroleptic malignant syndrome.

Authors:  P Sachdev; C Mason; D Hadzi-Pavlovic
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

5.  The neuroleptic malignant syndrome : report of three cases.

Authors:  R C Sharma; S Thakur; V Sharma
Journal:  Indian J Psychiatry       Date:  1996-04       Impact factor: 1.759
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.